COSMO Pharmaceuticals SA Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

COSMO Pharmaceuticals SA cash flow conversion efficiency. Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-12.70 Million ≈ $-16.06 Million USD) by net assets (CHF488.80 Million ≈ $617.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of COSMO Pharmaceuticals SA (2004–2025)

Cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2025. This chart illustrates how COSMO Pharmaceuticals SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View COSMO Pharmaceuticals SA (COPN) share price today for real-time trading data and today's change.

COSMO Pharmaceuticals SA Cash Flow Conversion Ratio Explained

COSMO Pharmaceuticals SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

COSMO Pharmaceuticals SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their cash flow conversion efficiency. Also see COPN market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aygaz AS IS:AYGAZ	0.003x
Doosan Fuel Cell Co Ltd KO:336260	-0.054x
Canfor Corporation TO:CFP	0.079x
Shanghai Datun Energy Resources Co Ltd SHG:600508	0.021x
Cairn Homes PLC IR:C5H	-0.020x
Hangzhou DPtech Technologies Co Ltd SHE:300768	0.013x
REDOX Ltd AU:RDX	0.066x
Rolls-Royce Holdings PLC LSE:RR	0.829x

Annual Cash Flow Conversion Efficiency for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2025. Review COPN cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF488.80 Million ≈ $617.97 Million	CHF-11.62 Million ≈ $-14.69 Million	-0.024x	-107.39%
2024-12-31	CHF505.09 Million ≈ $638.57 Million	CHF162.41 Million ≈ $205.33 Million	0.322x	+507.52%
2023-12-31	CHF429.04 Million ≈ $542.42 Million	CHF22.71 Million ≈ $28.71 Million	0.053x	-26.12%
2022-12-31	CHF463.79 Million ≈ $586.35 Million	CHF33.23 Million ≈ $42.01 Million	0.072x	+191.24%
2021-12-31	CHF512.68 Million ≈ $648.16 Million	CHF12.61 Million ≈ $15.94 Million	0.025x	-24.20%
2020-12-31	CHF400.12 Million ≈ $505.87 Million	CHF12.98 Million ≈ $16.42 Million	0.032x	+167.80%
2019-12-31	CHF393.73 Million ≈ $497.78 Million	CHF-18.85 Million ≈ $-23.83 Million	-0.048x	-109.50%
2018-12-31	CHF444.85 Million ≈ $562.42 Million	CHF-10.16 Million ≈ $-12.85 Million	-0.023x	-7.32%
2017-12-31	CHF470.12 Million ≈ $594.35 Million	CHF-10.01 Million ≈ $-12.65 Million	-0.021x	-133.50%
2016-12-31	CHF415.56 Million ≈ $525.38 Million	CHF26.41 Million ≈ $33.39 Million	0.064x	+165.40%
2015-12-31	CHF403.65 Million ≈ $510.32 Million	CHF-39.23 Million ≈ $-49.59 Million	-0.097x	-122.27%
2014-12-31	CHF152.29 Million ≈ $192.53 Million	CHF66.45 Million ≈ $84.01 Million	0.436x	+1084.01%
2013-12-31	CHF220.16 Million ≈ $278.34 Million	CHF8.11 Million ≈ $10.26 Million	0.037x	-80.04%
2012-12-31	CHF124.60 Million ≈ $157.53 Million	CHF23.00 Million ≈ $29.08 Million	0.185x	+3.72%
2011-12-31	CHF63.43 Million ≈ $80.20 Million	CHF11.29 Million ≈ $14.27 Million	0.178x	+33.42%
2010-12-31	CHF58.37 Million ≈ $73.79 Million	CHF7.79 Million ≈ $9.84 Million	0.133x	+105.80%
2009-12-31	CHF59.80 Million ≈ $75.60 Million	CHF3.88 Million ≈ $4.90 Million	0.065x	+122.39%
2008-12-31	CHF43.24 Million ≈ $54.66 Million	CHF-12.52 Million ≈ $-15.82 Million	-0.290x	-303.62%
2007-12-31	CHF35.15 Million ≈ $44.44 Million	CHF-2.52 Million ≈ $-3.19 Million	-0.072x	-106.31%
2006-12-31	CHF5.34 Million ≈ $6.76 Million	CHF6.08 Million ≈ $7.68 Million	1.137x	-57.78%
2005-12-31	CHF631.00K ≈ $797.75K	CHF1.70 Million ≈ $2.15 Million	2.694x	+1008.37%
2004-12-31	CHF-880.00K ≈ $-1.11 Million	CHF261.00K ≈ $329.97K	-0.297x	--

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General

Market Cap

$1.27 Billion

CHF1.01 Billion CHF

Market Cap Rank

#7622 Global

#112 in Switzerland

Share Price

CHF58.70

Change (1 day)

-2.17%

52-Week Range

CHF58.40 - CHF124.80

All Time High

CHF171.24